Home » U.S. FDA Delays Enforcement of Drug Sample Reporting Until October
U.S. FDA Delays Enforcement of Drug Sample Reporting Until October
April 6, 2012
Drug manufacturers and authorized distributors have until at least October to comply with a 2010 Affordable Care Act provision that requires submission of drug sample information to the U.S. Food and Drug Administration (FDA) by April 1 of each year.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor